Enzo Biochem (ENZ) Awarded U.S. Patent On More Efficient Vector For Use In Gene Therapy
6/6/2014 8:28:12 AM
NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYE:ENZ) announced that it has been assigned U.S. Patent Office Patent No. 8,742,090, related to the construct of an artificial vector capable of greater efficiency, in general, in targeting specific cells in the application of gene therapy and gene transfer technology.
Help employers find you! Check out all the jobs and post your resume.
comments powered by